“The vaccine against COVID-19 should be a global public good and its access needs to be equitable and universal,” European Commission spokesman Stefan de Keersmaecker told reporters.
The European Union insisted Thursday that any eventual coronavirus vaccine should be available to all countries after France’s Sanofi announced its plans to reserve first shipments for the US.
Sanofi’s chief executive Paul Hudson caused fury in France by announcing that US patients would get first access to a vaccine because Washington is helping to fund the research.
The EU organized a global fundraising effort this month for vaccine research which won around $8 billion — but Washington pointedly refused to take part.
“For us in one word it is very important that, as the virus is a global virus, that we work on this globally,” EU spokesman de Keersmaecker said.
The European Medicines Agency said Thursday that a vaccine might perhaps be ready in a year’s time, but dubbed this an “optimistic” scenario.
